Investor Relations

  • Overview
Investor Relations

Founded in 1999, Asymchem is a global integrated Contract Development and Manufacturing Organization (CDMO) providing drug R&D and manufacturing for leading pharmaceutical and biotech companies. Our mission is to drive smarter, greener and more cost-effective manufacturing to support clinical research and commercialization. Asymchem currently operates eight manufacturing facilities offering solutions ranging from early clinical stage to commercial stage, including R&D, cGMP production of advanced intermediates, APIs, formulations and clinical research services.

Asymchem Group, headquartered in Tianjin, P. R. China. is a publicly-traded company on the Shenzhen Stock Exchange & Hong Kong Stock Exchange (stock codes 002821.SZ & 6821.HK)

For investor-related questions, please contact us IR@asymchem.com.cn

Announcements

H

Financial Calender

Investment Highlights

Fact Sheet

All key information is presented in one page with PDF download function. Updated daily with the latest share data.

Read More

Financial Reports

Discover the latest financial reports showcasing our company's performance and fiscal strength.

Read More

Presentation Materials

Explore our comprehensive collection of presentation materials, offering insights and information on various topics.

Read More

IR Contact

Add: No. 71, Seventh Street, TEDA Tianjin, P.R. China

Zip Code: 300457

Tel: +86 22 6638 9560

Email: IR@asymchem.com.cn

Email Alert